Search research articles
Contact Us
Filters
Showing results (621-630 of 752) with videos related to
Page
of 76
Sort By:
The Journal of Molecular Diagnostics : JMD
|
December 17, 2013
Revisiting oversight and regulation of molecular-based laboratory-developed tests: a position statement of the Association for Molecular Pathology
Andrea Ferreira-Gonzalez, Rajyasree Emmadi, Stephen P Day, et al.
Cytotherapy
|
August 10, 2021
A biomarker-guided, prospective, phase 2 trial of pre-emptive graft-versus-host disease therapy using anti-thymocyte globulin
Rutvij A Khanolkar, Amit Kalra, Megan Kinzel, et al.
The American Journal of Cardiology
|
January 11, 1990
Clinical and regulatory implications of the Cardiac Arrhythmia Suppression Trial
C M Pratt, D C Brater, F E Harrell, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
June 3, 2018
Pharmacogenetic testing in the Veterans Health Administration (VHA): policy recommendations from the VHA Clinical Pharmacogenetics Subcommittee
Jason L Vassy, Annjanette Stone, John T Callaghan, et al.
The New England Journal of Medicine
|
August 14, 1986
Diltiazem and reinfarction in patients with non-Q-wave myocardial infarction. Results of a double-blind, randomized, multicenter trial
R S Gibson, W E Boden, P Theroux, et al.
Journal of the American Society of Nephrology : JASN
|
June 11, 1999
Acute and chronic renal effects of recombinant human TGF-beta2 in the rat
F J Kelly, S Anderson, M M Thompson, et al.
The American Journal of Cardiology
|
April 29, 1998
Mortality in the Survival With ORal D-sotalol (SWORD) trial: why did patients die?
C M Pratt, A J Camm, W Cooper, et al.
Circulation
|
February 18, 2004
Mortality in patients after a recent myocardial infarction: a randomized, placebo-controlled trial of azimilide using heart rate variability for risk stratification
A John Camm, Craig M Pratt, Peter J Schwartz, et al.
European Heart Journal
|
October 26, 1999
Evaluation of antiarrhythmic drug efficacy in patients with an ICD. Unlimited potential or replete with complexity and problems?
C M Pratt, A J Camm, J T Bigger, et al.
The Journal of Heart Transplantation
|
January 1, 1987
Evolution of hemodynamics after orthotopic heart and heart-lung transplantation: early restrictive patterns persisting in occult fashion
J B Young, C A Leon, H D Short, et al.
Page
of 76
Search research articles
Search
Showing results (621-630 of 752) with videos related to
Sort By:
Page
of 76
The Journal of Molecular Diagnostics : JMD
|
December 17, 2013
Revisiting oversight and regulation of molecular-based laboratory-developed tests: a position statement of the Association for Molecular Pathology
Andrea Ferreira-Gonzalez, Rajyasree Emmadi, Stephen P Day, et al.
Cytotherapy
|
August 10, 2021
A biomarker-guided, prospective, phase 2 trial of pre-emptive graft-versus-host disease therapy using anti-thymocyte globulin
Rutvij A Khanolkar, Amit Kalra, Megan Kinzel, et al.
The American Journal of Cardiology
|
January 11, 1990
Clinical and regulatory implications of the Cardiac Arrhythmia Suppression Trial
C M Pratt, D C Brater, F E Harrell, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
June 3, 2018
Pharmacogenetic testing in the Veterans Health Administration (VHA): policy recommendations from the VHA Clinical Pharmacogenetics Subcommittee
Jason L Vassy, Annjanette Stone, John T Callaghan, et al.
The New England Journal of Medicine
|
August 14, 1986
Diltiazem and reinfarction in patients with non-Q-wave myocardial infarction. Results of a double-blind, randomized, multicenter trial
R S Gibson, W E Boden, P Theroux, et al.
Journal of the American Society of Nephrology : JASN
|
June 11, 1999
Acute and chronic renal effects of recombinant human TGF-beta2 in the rat
F J Kelly, S Anderson, M M Thompson, et al.
The American Journal of Cardiology
|
April 29, 1998
Mortality in the Survival With ORal D-sotalol (SWORD) trial: why did patients die?
C M Pratt, A J Camm, W Cooper, et al.
Circulation
|
February 18, 2004
Mortality in patients after a recent myocardial infarction: a randomized, placebo-controlled trial of azimilide using heart rate variability for risk stratification
A John Camm, Craig M Pratt, Peter J Schwartz, et al.
European Heart Journal
|
October 26, 1999
Evaluation of antiarrhythmic drug efficacy in patients with an ICD. Unlimited potential or replete with complexity and problems?
C M Pratt, A J Camm, J T Bigger, et al.
The Journal of Heart Transplantation
|
January 1, 1987
Evolution of hemodynamics after orthotopic heart and heart-lung transplantation: early restrictive patterns persisting in occult fashion
J B Young, C A Leon, H D Short, et al.
Page
of 76